12 major players in the global platelet rich plasma market

Written by Shayna Korol | August 06, 2018 | Print  |

The global platelet rich plasma market is projected to increase from 2018 through 2026 at a 13.3 percent compound annual growth rate, according to a Credence Research report.

Here are 12 key market players:

1. Arthrex

2. Arteriocyte Medical Systems

3. DePuy Synthes

4. Biomet

5. Cesca Therapeutics

6. Dr. PRP America

7. EmCyte Corp.

8. AdiStem

9. Exactech

10. Nuo Therapeutics

11. Regen Lab

12. Harvest Technologies Corp.

More articles on biologics:
RTI Surgical & Aziyo Biologics ink deal: 4 things to know
Asterias Biotherapeutics' stem cell-derived treatment for spinal cord injury holds promise: 4 things to know
Ortho RTi receives extension on 2.1M+ warrants: 3 observations

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months